BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16502046)

  • 1. Factors affecting the survival of patients treated by standard nephroureterectomy for transitional cell carcinoma of the upper urinary tract.
    Ataus S; Onal B; Tunc B; Erozenci A; Cekmen A; Kural AR; Oner A
    Int Urol Nephrol; 2006; 38(1):9-13. PubMed ID: 16502046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ; Sherwood BT; Parkinson RJ; Obakponovwe O; Thomas SA; Taylor MC; England RC; Lemberger RJ
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
    Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years.
    Berger A; Haber GP; Kamoi K; Aron M; Desai MM; Kaouk JH; Gill IS
    J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors influencing survival after nephroureterectomy for transitional cell carcinoma of the upper urinary tract.
    Kobayashi Y; Saika T; Manabe D; Nasu Y; Kumon H
    Acta Med Okayama; 2010 Feb; 64(1):27-31. PubMed ID: 20200581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes.
    Lee BR; Jabbour ME; Marshall FF; Smith AD; Jarrett TW
    J Endourol; 1999 May; 13(4):289-94. PubMed ID: 10405908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
    Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
    Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper urinary tract transitional cell carcinoma: is there a best?
    Gunay LM; Akdogan B; Koni A; Inci K; Bilen CY; Ozen H
    Clin Genitourin Cancer; 2013 Mar; 11(1):39-44. PubMed ID: 23063580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors influencing survival after nephroureterectomy for transitional cell carcinoma of the upper urinary tract.
    Kobayashi Y; Saika T; Manabe D; Nasu Y; Kumon H
    Acta Med Okayama; 2011 Apr; 65(2):143-9. PubMed ID: 21525971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
    Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
    Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
    J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Liu Y; Lu J; Hong K; Huang Y; Ma L
    Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.